Beijing Scitop Bio-tech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Equivalents	209.11	99.7	108.64	191.6	875.36	481.82
Short-Term Investments	-	-	425.5	483	-	-
Trading Asset Securities	525.73	110.21	296.73	152.26	281.17	91.55
Cash & Short-Term Investments	734.84	209.9	830.86	826.86	1,157	573.37
Cash Growth	117.94%	-74.74%	0.48%	-28.51%	101.71%	-3.15%
Accounts Receivable	79.41	69.54	56.47	67.67	108.04	119.29
Other Receivables	1.09	1.13	-	-	-	-
Receivables	80.5	70.67	56.48	67.73	108.1	119.33
Inventory	38.3	46.47	46.6	39.22	50.93	52.85
Other Current Assets	66.98	650.3	20.77	21.74	11.42	7.05
Total Current Assets	920.62	977.34	954.71	955.55	1,327	752.59
Property, Plant & Equipment	895.76	877.77	548.7	375.05	243.87	213.23
Long-Term Investments	25.87	24.08	267.65	352.85	123.09	12.54
Goodwill	1.91	1.91	1.91	1.91	1.91	1.91
Other Intangible Assets	59.42	60.1	48.33	51.06	53.05	54.16
Long-Term Deferred Tax Assets	14.67	13.01	5.36	6.17	3.42	2.57
Long-Term Deferred Charges	1.52	1.68	2.31	2.98	0.11	0.28
Other Long-Term Assets	107.53	63.01	86.63	64.53	39.24	3.45
Total Assets	2,027	2,019	1,916	1,810	1,792	1,041
Accounts Payable	85.71	88.08	47.73	16.06	36.45	27.35
Accrued Expenses	5.17	14.69	13.07	14.38	18.97	12.33
Current Portion of Long-Term Debt	0.81	0.79	-	-	-	-
Current Portion of Leases	-	-	0.56	1.75	1.2	1.25
Current Income Taxes Payable	8.25	7.79	6.59	4.45	8.63	2.06
Current Unearned Revenue	16.74	14.07	23.13	17.12	16.77	18
Other Current Liabilities	2.38	2.19	5.11	4.87	3.27	1.49
Total Current Liabilities	119.05	127.6	96.19	58.64	85.28	62.47
Long-Term Leases	2.44	2.8	3.23	9.9	6.5	7.36
Long-Term Unearned Revenue	46.19	43.83	25.14	5.86	1.32	2.19
Long-Term Deferred Tax Liabilities	1.85	1.85	1.47	2.69	2.01	1.31
Total Liabilities	169.53	176.08	126.03	77.1	95.11	73.33
Common Stock	263.5	263.5	263.5	263.5	175.66	148.53
Additional Paid-In Capital	1,105	1,105	1,107	1,105	1,197	530.88
Retained Earnings	488.98	474.03	419.03	364.2	323.42	287.99
Comprehensive Income & Other	0	0	0	-	-	-
Total Common Equity	1,858	1,843	1,790	1,733	1,697	967.4
Shareholders' Equity	1,858	1,843	1,790	1,733	1,697	967.4
Total Liabilities & Equity	2,027	2,019	1,916	1,810	1,792	1,041
Total Debt	3.25	3.59	3.79	11.65	7.7	8.61
Net Cash (Debt)	731.6	206.32	827.08	815.21	1,149	564.76
Net Cash Growth	119.27%	-75.06%	1.46%	-29.04%	103.42%	-4.61%
Net Cash Per Share	2.80	0.79	3.16	3.05	5.12	2.54
Filing Date Shares Outstanding	249.19	261.61	263.5	263.5	263.5	222.8
Total Common Shares Outstanding	249.19	261.61	263.5	263.5	263.5	222.8
Working Capital	801.57	849.74	858.52	896.91	1,242	690.11
Book Value Per Share	7.46	7.04	6.79	6.58	6.44	4.34
Tangible Book Value	1,796	1,781	1,739	1,680	1,642	911.33
Tangible Book Value Per Share	7.21	6.81	6.60	6.38	6.23	4.09
Buildings	-	-	261.99	142.59	142.59	142.45
Machinery	-	-	191.42	122.89	97.99	87.49
Construction In Progress	-	-	172.07	156.65	38.74	3.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.